Axiom Investment Management LLC Axsome Therapeutics, Inc. Transaction History

Axiom Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Mar 16, 2021	SELL	$41.2 - $101.31 $164,800 - $405,240	-4,000 Closed	0 $0
Q4 2019 Mar 16, 2021	BUY	$16.71 - $106.24 $66,840 - $424,960	4,000 New	4,000 $413,000
Q3 2019 Mar 16, 2021	SELL	$20.24 - $29.16 $161,920 - $233,280	-8,000 Closed	0 $0
Q2 2019 Mar 16, 2021	BUY	$13.46 - $25.75 $107,680 - $206,000	8,000 New	8,000 $206,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.73B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Axiom Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Axiom Investment Management LLC with notifications on news.